Carisma Therapeutics, Inc. (CARM)
0.0396
0.00 (0.00%)
USD |
OTCM |
Feb 20, 16:00
Carisma Therapeutics EPS Diluted (Quarterly) : 1.066 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 44.72M |
| Revenue (Quarterly) | 45.25M |
| Total Expenses (Quarterly) | 0.533M |
| Enterprise Value | -0.3579M |
| Profit Margin (Quarterly) | 98.82% |
| Earnings Yield | 475.0% |
| Operating Earnings Yield | 655.1% |
| Normalized Earnings Yield | 514.14 |